Patents Assigned to Platform Diagnostics Limited
  • Patent number: 9201065
    Abstract: The invention relates to agglutination assays and related kits, reagents and devices. In particular methods of assaying small analytes having few epitopes are disclosed, by means of using hub moieties to which multiple analytes may be bound by a first epitope, together with a further moiety capable of binding a second analyte epitope and which is also capable of binding to a detectable particle. Stable agglutinated complexes may be so formed, which may used as the basis for various assay formats.
    Type: Grant
    Filed: November 13, 2006
    Date of Patent: December 1, 2015
    Assignee: Platform Diagnostics Limited
    Inventors: Carolyn Jennifer Ruddell, Gerald John Allen, Douglas Robert Evans, Elizabeth Burke
  • Patent number: 9028771
    Abstract: The invention provides a modified form of saturation assay, which is based on the measurement of a free or unbound labelled reagent fraction (such that there is an increase in signal in the presence of analyte) and employs trapping zones to concentrate said unbound or free labelled fraction to avoid loss of sensitivity. Preferably, the assay is a membrane assay.
    Type: Grant
    Filed: November 9, 2007
    Date of Patent: May 12, 2015
    Assignee: Platform Diagnostics Limited
    Inventors: Douglas Robert Evans, Gerald John Allen, Carolyn Jennifer Ruddell
  • Patent number: 8685715
    Abstract: The present invention provides an agglutination based assay system for determining the presence and/or amount of analyte in a sample comprising a test device having one or more capillary pathways comprising detection regions adapted for non-visual detection of a sample which is releasably engageable with a reader which comprises detection means for detecting the sample at the detection regions in each of said capillary pathways and electronic means for indicating the presence and/or amount of analyte.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: April 1, 2014
    Assignee: Platform Diagnostics Limited
    Inventors: Stephen John Minter, Damian Joseph Peter Bond, Carolyn Jennifer Ruddell
  • Publication number: 20130071950
    Abstract: A sample testing device for testing for the presence of a component of interest in a liquid sample includes: (a) a capillary pathway having an upstream end and a downstream end and incorporating a reagent system capable of causing agglutination with the component; (b) optionally, a control capillary pathway; (c) a sampling region to which the liquid sample is applied and from which the sample is able to enter the upstream ends of the test and control capillaries; (d) a power source; (e) detection arrangements electrically associated with the power source for detecting the presence of liquid at a downstream region of the capillaries; (f) a display operated by the power source for indicating the result of the test; and (g) a signal processor associated with the power source, detection arrangement and display for evaluating the result of the test and providing the result on the display.
    Type: Application
    Filed: September 14, 2012
    Publication date: March 21, 2013
    Applicant: PLATFORM DIAGNOSTICS LIMITED
    Inventors: Damian Joseph Peter BOND, Stephen John MINTER, Timothy John MINTER
  • Patent number: 8283182
    Abstract: A sample testing device for testing for the presence of a component of interest in a liquid sample comprises: (a) at least one capillary pathway which has an upstream end and a downstream end and which incorporates a reagent system capable of causing agglutination with said component to be detected (the test capillary); (b) preferably, but optionally, at least one capillary pathway having an upstream end and a downstream end (the control capillary); (c) a sampling region to which the liquid sample is applied and from which the sample is able to enter the upstream ends of the test capillary(s) and if present the control capillary(s); (d) a power source; (c) detection arrangements electrically associated with said power source for detecting the presence of liquid at a downstream region of said testing capillary(s) and if present the control capillary(s); (f) display means operated by said power source for indicating the result of the test; and (g) signal processing means associated with the power source, detect
    Type: Grant
    Filed: June 11, 2010
    Date of Patent: October 9, 2012
    Assignee: Platform Diagnostics Limited
    Inventors: Damian Joseph Peter Bond, Stephen John Minter, Timothy John Minter
  • Publication number: 20110136257
    Abstract: A sample testing device for testing for the presence of a component of interest in a liquid sample comprises: (a) at least one capillary pathway which has an upstream end and a downstream end and which incorporates a reagent system capable of causing agglutination with said component to be detected (the test capillary); (b) preferably, but optionally, at least one capillary pathway having an upstream end and a downstream end (the control capillary); (c) a sampling region to which the liquid sample is applied and from which the sample is able to enter the upstream ends of the test capillary(s) and if present the control capillary(s); (d) a power source; (c) detection arrangements electrically associated with said power source for detecting the presence of liquid at a downstream region of said testing capillary(s) and if present the control capillary(s); (f) display means operated by said power source for indicating the result of the test; and (g) signal processing means associated with the power source, detect
    Type: Application
    Filed: June 11, 2010
    Publication date: June 9, 2011
    Applicant: PLATFORM DIAGNOSTICS LIMITED
    Inventors: Damian Joseph Peter BOND, Stephen John MINTER, Timothy John MINTER
  • Publication number: 20100062544
    Abstract: The invention provides a modified form of saturation assay, which is based on the measurement of a free or unbound labelled reagent fraction (such that there is an increase in signal in the presence of analyte) and employs trapping zones to concentrate said unbound or free labelled fraction to avoid loss of sensitivity. Preferably, the assay is a membrane assay.
    Type: Application
    Filed: November 9, 2007
    Publication date: March 11, 2010
    Applicant: PLATFORM DIAGNOSTICS LIMITED
    Inventors: Douglas Robert Evans, Gerald John Allen, Carolyn Jennifer Ruddell
  • Publication number: 20090035743
    Abstract: The present invention provides an agglutination based assay system for determining the presence and/or amount of analyte in a sample comprising a test device having one or more capillary pathways comprising detection regions adapted for non-visual detection of a sample which is releasably engageable with a reader which comprises detection means for detecting the sample at the detection regions in each of said capillary pathways and electronic means for indicating the presence and/or amount of analyte. Also provided are the individual test device and reader components, and an assay method using the system.
    Type: Application
    Filed: October 28, 2005
    Publication date: February 5, 2009
    Applicant: PLATFORM DIAGNOSTICS LIMITED
    Inventors: Stephen John Minter, Damien Joseph Peter Bond, Carolyn Jennifer Ruddell
  • Publication number: 20080248504
    Abstract: The invention relates to agglutination assays and related kits, reagents and devices. In particular methods of assaying small analytes having few epitopes are disclosed, by means of using hub moieties to which multiple analytes may be bound by a first epitope, together with a further moiety capable of binding a second analyte epitope and which is also capable of binding to a detectable particle. Stable agglutinated complexes may be so formed, which may used as the basis for various assay formats.
    Type: Application
    Filed: November 13, 2006
    Publication date: October 9, 2008
    Applicant: Platform Diagnostics Limited
    Inventors: Carolyn Jennifer Ruddell, Gerald John Allen, Douglas Robert Evans, Elizabeth Burke
  • Publication number: 20060194342
    Abstract: A sample testing device (100) for testing for the presence of a component of interest in a liquid sample comprises: (a) at least one capillary pathway (120) which has an upstream end and a downstream end and which incorporates a reagent system capable of causing agglutination with said component to be detected (the test capillary); (b) preferably, but optionally, at least one capillary pathway (121) having an upstream end and a downstream end (the control capillary); (c) a sampling region (114) to which the liquid sample is applied and from which the sample is able to enter the upstream ends of the test capillary(s) (120) and if present the control capillary(s) (121); (d) a power source (108, 109); (e) detection arrangements (117, 118) electrically associated with said power source (108, 109) for detecting the presence of liquid at a downstream region of said testing capillary(s) (120) and if present the control capillary(s) (121); (f) display means (113) operated by said power source (108, 109) for indicatin
    Type: Application
    Filed: March 18, 2004
    Publication date: August 31, 2006
    Applicant: Platform Diagnostics Limited
    Inventors: Damian Bond, Stephen Minter, Timothy Minter